Identity
- Trade Name
- VersaWrap FDA UDI
- Generic Name
- Nerve guide, synthetic polymer, bioabsorbable FDA UDI
- Device Name
- VersaWrap is an absorbable implant (device), designed to serve as an interface between target tissues and surrounding tissues to provide a non-constricting, protective encasement. VersaWrap consists of a clear Sheet and a wetting Solution. The clear Sheet is a thin membrane of crosslinked calcium alginate and glycosaminoglycan. VersaWrap Sheet is easy to handle, conformable, and is designed for placement under, around, or over injured tissues and/or surrounding tissues. VersaWrap Sheet is supplied sterile, non-pyrogenic, for single use, in double peel pouches. The VersaWrap Solution is applied to the Sheet to render the Sheet a gelatinous, tissue adherent layer (gel in situ). The aqueous citrate Solution is provided sterile, non-pyrogenic, for single use, in a dropper, packaged in a double peel pouch. FDA UDI
- Model / Reference
- VTP-2201 FDA UDI
- Description
- VersaWrap is an absorbable implant (device), designed to serve as an interface between target tissues and surrounding tissues to provide a non-constricting, protective encasement. VersaWrap consists of a clear Sheet and a wetting Solution. The clear Sheet is a thin membrane of crosslinked calcium alginate and glycosaminoglycan. VersaWrap Sheet is easy to handle, conformable, and is designed for placement under, around, or over injured tissues and/or surrounding tissues. VersaWrap Sheet is supplied sterile, non-pyrogenic, for single use, in double peel pouches. The VersaWrap Solution is applied to the Sheet to render the Sheet a gelatinous, tissue adherent layer (gel in situ). The aqueous citrate Solution is provided sterile, non-pyrogenic, for single use, in a dropper, packaged in a double peel pouch. FDA UDI
Identifiers
- Catalog Number
- VTP-2201 FDA UDI
- Primary DI / UDI-DI
- B454VTP22010 FDA UDI
- FDA Product Code
- JXI FDA UDIFTM FDA UDIOWW FDA UDI
- GMDN Term
- Nerve guide, synthetic polymer, bioabsorbable FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 882.5275 FDA UDI878.3300 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
Yes
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
MR Safe FDA UDI
Dimensions & Sizes
- Size
- Total Volume — 1 Milliliter FDA UDILength — 2 Inch FDA UDIWidth — 2 Inch FDA UDILength — 5 Centimeter FDA UDIWidth — 5 Centimeter FDA UDI
Category: Nerve guide, synthetic polymer, bioabsorbableTendon spacer
VersaWrap by Alafair Biosciences, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Tendon spacer.
- InSpace™ — ORTHO-SPACE LTD · Class II
- Geistlich Nexo-Gide® — Geistlich Pharma AG · Class II
- InSpace™ — ORTHO-SPACE LTD · Class II
- Tenoglide® — Integra Lifesciences Corp. · Class II
- Tenoglide® — Integra Lifesciences Corp. · Class II
- Geistlich Nexo-Gide® — Geistlich Pharma AG · Class II
- Geistlich Nexo-Gide® — Geistlich Pharma AG · Class II
- InSpace™ — ORTHO-SPACE LTD · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Alafair Biosciences, Inc.
Sources (1)
- FDA UDI ceb7320b-f9ad-421c-b3e8-acb3eb84b3c4 36 fields · synced Jun 8, 2026